Integrative transcriptome analysis of malignant pleural mesothelioma reveals a clinically relevant immune-based classification

Ania Alay; David Cordero; Sara Hijazo-Pechero; Elisabet Aliagas; Adriana Lopez-Doriga; Raúl Marín; Ramón Palmero; Roger Llatjós; Ignacio Escobar; Ricard Ramos; Susana Padrones; Víctor Moreno; Ernest Nadal; Xavier Solé

doi:10.1101/2020.08.14.20174789

Integrative transcriptome analysis of malignant pleural mesothelioma reveals a clinically relevant immune-based classification

View ORCID ProfileAnia Alay, View ORCID ProfileDavid Cordero, Sara Hijazo-Pechero, View ORCID ProfileElisabet Aliagas, Adriana Lopez-Doriga, Raúl Marín, Ramón Palmero, Roger Llatjós, Ignacio Escobar, Ricard Ramos, Susana Padrones, Víctor Moreno, View ORCID ProfileErnest Nadal, View ORCID ProfileXavier Solé

doi: https://doi.org/10.1101/2020.08.14.20174789

Now published in Journal for ImmunoTherapy of Cancer doi: 10.1136/jitc-2020-001601

Ania Alay

1Unit of Bioinformatics for Precision Oncology, Catalan Institute of Oncology (ICO), L’Hospitalet de Llobregat, Barcelona, Spain

2Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Ania Alay

David Cordero

1Unit of Bioinformatics for Precision Oncology, Catalan Institute of Oncology (ICO), L’Hospitalet de Llobregat, Barcelona, Spain

2Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain

3CIBER (Consorcio de Investigación Biomédica en Red) Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for David Cordero

Sara Hijazo-Pechero

1Unit of Bioinformatics for Precision Oncology, Catalan Institute of Oncology (ICO), L’Hospitalet de Llobregat, Barcelona, Spain

2Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Elisabet Aliagas

2Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Elisabet Aliagas

Adriana Lopez-Doriga

1Unit of Bioinformatics for Precision Oncology, Catalan Institute of Oncology (ICO), L’Hospitalet de Llobregat, Barcelona, Spain

2Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain

3CIBER (Consorcio de Investigación Biomédica en Red) Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Raúl Marín

1Unit of Bioinformatics for Precision Oncology, Catalan Institute of Oncology (ICO), L’Hospitalet de Llobregat, Barcelona, Spain

2Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ramón Palmero

2Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain

4Thoracic Oncology Unit, Department of Medical Oncology, Catalan Institute of Oncology (ICO), L’Hospitalet del Llobregat, Barcelona, Spain

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Roger Llatjós

5Department of Pathology. Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ignacio Escobar

6Department of Thoracic Surgery. Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ricard Ramos

6Department of Thoracic Surgery. Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Susana Padrones

7Department of Respiratory Medicine. Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Víctor Moreno

2Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain

3CIBER (Consorcio de Investigación Biomédica en Red) Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain

8Oncology Data Analytics Program, Catalan Institute of Oncology (ICO) and Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ernest Nadal

2Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain

4Thoracic Oncology Unit, Department of Medical Oncology, Catalan Institute of Oncology (ICO), L’Hospitalet del Llobregat, Barcelona, Spain

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Ernest Nadal
For correspondence: x.sole@iconcologia.net esnadal@iconcologia.net

Xavier Solé

1Unit of Bioinformatics for Precision Oncology, Catalan Institute of Oncology (ICO), L’Hospitalet de Llobregat, Barcelona, Spain

2Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain

3CIBER (Consorcio de Investigación Biomédica en Red) Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Xavier Solé
For correspondence: x.sole@iconcologia.net esnadal@iconcologia.net

Abstract
Full Text
Info/History
Metrics
Supplementary material
Data/Code
Preview PDF

Data Availability

Data used in this study are available in public, open access repositories.

PreviousNext

Posted August 15, 2020.

Download PDF

Print/Save Options

Download PDF Full Text & In-line Figures XML

More Info

Author Declarations

Supplementary Material

Data/Code

Integrative transcriptome analysis of malignant pleural mesothelioma reveals a clinically relevant immune-based classification

Ania Alay, David Cordero, Sara Hijazo-Pechero, Elisabet Aliagas, Adriana Lopez-Doriga, Raúl Marín, Ramón Palmero, Roger Llatjós, Ignacio Escobar, Ricard Ramos, Susana Padrones, Víctor Moreno, Ernest Nadal, Xavier Solé

medRxiv 2020.08.14.20174789; doi: https://doi.org/10.1101/2020.08.14.20174789

Now published in Journal for ImmunoTherapy of Cancer doi: 10.1136/jitc-2020-001601

Share This Article:

Citation Tools

Get QR code

Tweet Widget

Subject Area

Oncology

Reviews and Context

Comment

TRIP Peer Reviews

Community Reviews

Automated Services

Blogs/Media

Author Videos

Subject Areas

All Articles

Addiction Medicine (417)
Allergy and Immunology (739)
Anesthesia (216)
Cardiovascular Medicine (3160)
Dentistry and Oral Medicine (353)
Dermatology (268)
Emergency Medicine (469)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1120)
Epidemiology (13128)
Forensic Medicine (15)
Gastroenterology (876)
Genetic and Genomic Medicine (4954)
Geriatric Medicine (456)
Health Economics (760)
Health Informatics (3114)
Health Policy (1112)
Health Systems and Quality Improvement (1153)
Hematology (417)
HIV/AIDS (984)
Infectious Diseases (except HIV/AIDS) (14426)
Intensive Care and Critical Care Medicine (894)
Medical Education (460)
Medical Ethics (121)
Nephrology (509)
Neurology (4704)
Nursing (249)
Nutrition (697)
Obstetrics and Gynecology (856)
Occupational and Environmental Health (771)
Oncology (2430)
Ophthalmology (690)
Orthopedics (272)
Otolaryngology (335)
Pain Medicine (313)
Palliative Medicine (88)
Pathology (523)
Pediatrics (1260)
Pharmacology and Therapeutics (533)
Primary Care Research (530)
Psychiatry and Clinical Psychology (4043)
Public and Global Health (7274)
Radiology and Imaging (1625)
Rehabilitation Medicine and Physical Therapy (972)
Respiratory Medicine (951)
Rheumatology (464)
Sexual and Reproductive Health (483)
Sports Medicine (409)
Surgery (526)
Toxicology (66)
Transplantation (223)
Urology (193)

Comments

medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions and read our Comment Policy before commenting. The content of a comment is not endorsed by medRxiv.

medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors.

Community reviews for this article:

There are no community reviews for this paper.

Automated Evaluations

Certain services provide automated analysis of preprints. Analyses invited by the authors are displayed at the top of this tab. Those done independently of authors are shown underneath . None of these analyses is endorsed by medRxiv.

Automated Evaluations:

There are no automated evaluations for this paper.

Integrative transcriptome analysis of malignant pleural mesothelioma reveals a clinically relevant immune-based classification

Data Availability

Subject Area

Follow this preprint